Osteopontin Deficiency Suppresses Tumor Necrosis Factor-α-Induced Apoptosis in Chondrocytes.

Cartilage

Department of Molecular Pharmacology, Tokyo Medical and Dental University, Tokyo, Japan ; Medical Top Track (MTT) Program, Tokyo Medical and Dental University, Tokyo, Japan ; Global Center of Excellence Program, Tokyo Medical and Dental University, Tokyo, Japan ; Core to Core Program, Tokyo Medical and Dental University, Tokyo, Japan ; Hard Tissue Genome Research Center, Tokyo Medical and Dental University, Tokyo, Japan.

Published: January 2012

Objective: Apoptosis of chondrocytes in articular cartilage has been observed in rheumatoid arthritis patients. However, molecules involved in such chondrocyte apoptosis in arthritic joints have not been fully understood. We previously observed that apoptosis of chondrocytes is enhanced in a murine arthritis model induced by injection with anti-type II collagen antibodies and lipopolysaccharide (mAbs/LPS), and osteopontin (OPN) deficiency suppresses chondrocyte apoptosis in this arthritis model in vivo. To understand how OPN deficiency renders resistance against chondrocyte apoptosis, we examined the cellular basis for this protection.

Design: Chondrocytes were prepared from wild-type and OPN-deficient mouse ribs, and tumor necrosis factor (TNF)-α-induced cell death was examined based on lactate dehydrogenase (LDH) release assay and TUNEL assay.

Results: TNF-α treatment induced LDH release in wild-type chondrocytes, while OPN deficiency suppressed such LDH release in the cultures of these cells. TNF-α-induced increase in the number of TUNEL-positive cells was observed in wild-type chondrocytes, while OPN deficiency in chondrocytes suppressed the TNF-α induction of TUNEL-positive cells. OPN deficiency suppressed TNF-α-induced increase in caspase-3 activity in chondrocytes in culture. Furthermore, OPN overexpression in chondrocytes enhanced TNF-α-induced apoptosis.

Conclusion: These results indicated that the presence of OPN in chondrocytes is involved in the susceptibility of these cells to TNF-α-induced apoptosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297182PMC
http://dx.doi.org/10.1177/1947603511421502DOI Listing

Publication Analysis

Top Keywords

opn deficiency
20
apoptosis chondrocytes
12
chondrocyte apoptosis
12
ldh release
12
chondrocytes
10
deficiency suppresses
8
tumor necrosis
8
chondrocytes enhanced
8
arthritis model
8
wild-type chondrocytes
8

Similar Publications

Glioblastoma (GB) is one of the most aggressive and treatment-resistant cancers due to its complex tumor microenvironment (TME). We previously showed that GB progression is dependent on the aberrant induction of chaperone-mediated autophagy (CMA) in pericytes (PCs), which promotes TME immunosuppression through the PC secretome. The secretion of extracellular matrix (ECM) proteins with anti-tumor (Lumican) and pro-tumoral (Osteopontin, OPN) properties was shown to be dependent on the regulation of GB-induced CMA in PCs.

View Article and Find Full Text PDF

Milk osteopontin has high iron-binding capacity and facilitates iron absorption in intestinal cells.

J Dairy Sci

January 2025

Department of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus C, Denmark. Electronic address:

Insufficient absorption of iron and the consequent development of iron deficiency have serious health consequences. Hence, identification and development of iron delivery systems that can increase the bioavailability and uptake of dietary iron are important. Osteopontin (OPN) is an acidic and highly phosphorylated integrin-binding protein found in milk where it exists as a full-length protein and as N-terminally derived fragments.

View Article and Find Full Text PDF

Extract of Ameliorates Postmenopausal Osteoporosis by Promoting Osteoblast Proliferation and Differentiation.

Cells

December 2024

Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei 230032, China.

Postmenopausal osteoporosis (PMOP) is a bone disease characterized by bone thinning and an increased risk of fractures due to estrogen deficiency. Current PMOP therapies often result in adverse side effects. The traditional medicinal plant is commonly used to strengthen bones and support kidney function, but its role in treating PMOP is not well understood.

View Article and Find Full Text PDF

Inducible T-cell costimulator (ICOS, CD278) is a costimulatory receptor primarily expressed by activated T cells. It binds to ICOS ligand (ICOSL, CD275), which is expressed by various immune and non-immune cell types, particularly in inflamed tissues. ICOSL can also bind to osteopontin (OPN), a protein that functions both as a component of the extracellular matrix and as a soluble pro-inflammatory cytokine.

View Article and Find Full Text PDF

Evaluating osteopontin levels in pediatric celiac disease: a potential indicator for mucosal atrophy and osteoporosis.

Eur J Pediatr

November 2024

Department of Pediatrics, Division of Pediatric Gastroenterology and Hepatology, Eskisehir Osmangazi University Faculty of Medicine, Meselik, Eskisehir, 26040, Türkiye.

Article Synopsis
  • The study investigated the levels of Osteopontin (OPN) in patients diagnosed with Celiac disease (CD) compared to healthy controls, finding higher OPN levels in CD patients.
  • It highlighted that OPN levels were significantly elevated in patients with osteoporosis compared to those with normal bone mineral density (BMD).
  • The research suggests that serum OPN may be useful in assessing mucosal atrophy and osteoporosis in CD patients, though more research is needed to confirm its clinical significance.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!